STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Trulieve Cannabis (TCNNF) Chief Sales Officer reports 16,744-share RSU tax withholding

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Trulieve Cannabis Corp.'s Chief Sales Officer reported an automatic share withholding related to equity compensation. On December 1, 2025, 16,744 subordinate voting shares were disposed of at $5.39 per share under transaction code “F,” which indicates shares withheld to cover tax obligations on vesting restricted stock units. After this tax-related transaction, the officer directly beneficially owned 174,709 subordinate voting shares of Trulieve Cannabis Corp. This filing reflects routine administration of previously granted RSUs rather than an open‑market trade.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Morey Timothy

(Last) (First) (Middle)
C/O TRULIEVE CANNABIS CORP.
6749 BEN BOSTIC ROAD

(Street)
QUINCY FL 32351

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Sales Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Subordinate Voting Shares 12/01/2025 F 16,744(1) D $5.39 174,709 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares withheld for payment of tax liability in connection with vesting of restricted stock units ("RSUs") on December 1, 2025, the grant of which RSUs to the reporting person were previously reported on Form 4.
/s/ Eric Powers, as Attorney-in-Fact 12/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Trulieve Cannabis Corp. (TCNNF) report in this Form 4?

The Chief Sales Officer of Trulieve Cannabis Corp. reported the disposition of 16,744 subordinate voting shares on December 1, 2025, in connection with restricted stock units vesting and related tax withholding.

Was the Trulieve (TCNNF) insider sale an open-market transaction?

No. The transaction is coded “F,” indicating shares withheld for payment of tax liability arising from the vesting of restricted stock units, rather than a discretionary open‑market sale.

At what price were the Trulieve insider shares reported as disposed?

The filing shows the 16,744 subordinate voting shares were disposed of at a price of $5.39 per share in the tax‑withholding transaction.

How many Trulieve Cannabis Corp. shares does the reporting person own after this transaction?

Following the reported tax‑withholding transaction, the Chief Sales Officer directly beneficially owned 174,709 subordinate voting shares of Trulieve Cannabis Corp.

What is the role of the reporting person in Trulieve Cannabis Corp. (TCNNF)?

The reporting person is an officer of Trulieve Cannabis Corp., serving as the company’s Chief Sales Officer, and is subject to insider reporting requirements for equity transactions.

What triggered the Trulieve insider tax-withholding transaction on December 1, 2025?

The filing explains that the shares represent withholding for tax liability in connection with the vesting of restricted stock units (RSUs) granted earlier to the reporting person.

Trulieve Cannabis Corp

OTC:TCNNF

TCNNF Rankings

TCNNF Latest News

TCNNF Latest SEC Filings

TCNNF Stock Data

1.35B
184.53M
3.86%
5.15%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Quincy